The presented data clearly demonstrated that the long-held belief that IHD (even history of AMI) are significant risk factors for poor outcomes in HF patients is true predominantly when IHD is accompanied by metabolic disturbances such as elevated PTH, urea, GGT/ALT ratio, low albumin or 25(OH)D levels. The gene discussed is PTH; the disease is hydrops fetalis.